171 related articles for article (PubMed ID: 22179672)
21. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
[TBL] [Abstract][Full Text] [Related]
22. CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
Schreiber S; Dressler LS; Loffredo-Verde E; Asen T; Färber S; Wang W; Groll T; Chakraborty A; Kolbe F; Kreer C; Kosinska AD; Simon S; Urban S; Klein F; Riddell SR; Protzer U
Front Immunol; 2024; 15():1340619. PubMed ID: 38711498
[TBL] [Abstract][Full Text] [Related]
23. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
[TBL] [Abstract][Full Text] [Related]
24. Cell display library for gene cloning of variable regions of human antibodies to hepatitis B surface antigen.
Higuchi K; Araki T; Matsuzaki O; Sato A; Kanno K; Kitaguchi N; Ito H
J Immunol Methods; 1997 Mar; 202(2):193-204. PubMed ID: 9107308
[TBL] [Abstract][Full Text] [Related]
25. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
26. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library.
Chen YC; Delbrook K; Dealwis C; Mimms L; Mushahwar IK; Mandecki W
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1997-2001. PubMed ID: 8700874
[TBL] [Abstract][Full Text] [Related]
27. Different antibody responses against hepatitis B surface antigen among mouse strains transfected with mutant viral DNA.
Hasegawa K; Joh R; Iizuka A; Naritomi T; Kanai N; Ogawa M; Torii N; Hayashi N
J Gastroenterol; 2002; 37(12):1035-41. PubMed ID: 12522535
[TBL] [Abstract][Full Text] [Related]
28. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
29. Evolution of full-length genomes of HBV quasispecies in sera of patients with a coexistence of HBsAg and anti-HBs antibodies.
Zhou TC; Li X; Li L; Li XF; Zhang L; Wei J
Sci Rep; 2017 Apr; 7(1):661. PubMed ID: 28386078
[TBL] [Abstract][Full Text] [Related]
30. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
31. In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.
Kim SH; Kim SH; Oh HK; Ryu CJ; Park SY; Hong HJ
Exp Mol Med; 2008 Feb; 40(1):145-9. PubMed ID: 18305407
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.
Cooreman MP; van Roosmalen MH; te Morsche R; Sünnen CM; de Ven EM; Jansen JB; Tytgat GN; de Wit PL; Paulij WP
Hepatology; 1999 Nov; 30(5):1287-92. PubMed ID: 10534351
[TBL] [Abstract][Full Text] [Related]
33. [Construction of dengue virus-specific full-length fully human antibody libraries by mammalian display technology].
Wen Y; Lan K; Wang J; Yu J; Qu Y; Zhao W; Zhang F; Tan W; Cao H; Zhou C
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):847-52. PubMed ID: 23803195
[TBL] [Abstract][Full Text] [Related]
34. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants.
Chong-Jin O; Wei Ning C; Shiuan K; Gek Keow L
J Infect Dis; 1999 Jan; 179(1):259-63. PubMed ID: 9841851
[TBL] [Abstract][Full Text] [Related]
35. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus-reactive human T lymphocyte clones: antigen specificity and helper function for antibody synthesis.
Celis E; Kung PC; Chang TW
J Immunol; 1984 Mar; 132(3):1511-6. PubMed ID: 6198394
[TBL] [Abstract][Full Text] [Related]
37. Current aspects of hepatitis B surface antigen mutants in Singapore.
Oon CJ; Chen WN
J Viral Hepat; 1998 Nov; 5 Suppl 2():17-23. PubMed ID: 9857356
[TBL] [Abstract][Full Text] [Related]
38. Subunit, recombinant and synthetic hepatitis B vaccines.
Zuckerman AJ
Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B monoclonal antibody testing.
Ben-Porath E; Fujita YK; Wands JR
Prog Liver Dis; 1986; 8():347-66. PubMed ID: 2424047
[No Abstract] [Full Text] [Related]
40. Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine.
Ge G; Wang S; Han Y; Zhang C; Lu S; Huang Z
PLoS One; 2012; 7(7):e41573. PubMed ID: 22844502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
